News

Return of FDA official targeted by Trump allies hits biotech shares
Sarepta shares dropped as much as 5.2 per cent on Monday amid volatile trading, while those of Replimune — another gene ...
Nationwide Deodorant Recall Update as FDA Sets Risk Level
The recall of three Power Stick deodorants, affecting more than 67,000 products sold across the United States, was voluntary issued by Pennsylvania-based maker A.P. Deauville on July 10. FDA ...
FDA Approves Ajovy for Migraine Prevention in Children and Teens
By Lori Solomon HealthDay ReporterMONDAY, Aug. 11, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
Medscape7h
FDA Okays Ketamine-Based Med for Post-Surgical Pain
The FDA has approved the racemic ketamine product known as KETARx (PharmaTher Holdings) for the treatment of post-surgical ...
GSK's antibiotic gets FDA priority review for oral treatment of gonorrhoea
British drugmaker GSK said on Monday that the U.S. Food and Drug Administration has accepted its application for priority ...
FDA Rehires Controversial Biologics Chief Just Days After Trump Fired Him
Vinay Prasad is once again head of the FDA’s Center for Biologics Evaluation and Research, after Laura Loomer led a campaign ...
Hosted on MSN2h
WeightWatchers shuns compounded semaglutide amid FDA rules
The move means WeightWatchers is in line with US Food and Drug Administration (FDA) deadlines for pharmacies and ...
Leadership Turmoil at FDA Adds to Difficult Stretch for Biotech Investors
Dr. Vinay Prasad, leader of the FDA division responsible for approving vaccines, is returning to the agency less than two ...